Management of comorbidities in difficult and severe asthma

Difficult-to-treat and severe asthma are challenging clinical entities. In the face of suboptimal asthma control, the temptation for clinicians is to reflexively escalate asthma-directed therapy, including increasing exposure to corticosteroids and commencement of costly but potent biologic therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Jehangir, Moran, Barry, McCarthy, Cormac, Butler, Marcus W., Franciosi, Alessandro N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644109/
https://www.ncbi.nlm.nih.gov/pubmed/38020342
http://dx.doi.org/10.1183/20734735.0133-2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644109/
https://www.ncbi.nlm.nih.gov/pubmed/38020342
http://dx.doi.org/10.1183/20734735.0133-2023

Ejemplares similares